• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7214
Device Problems Break (1069); Material Rupture (1546)
Patient Problem No Code Available (3191)
Event Date 11/07/2018
Event Type  Injury  
Event Description
It was reported that balloon rupture and shaft break occurred.The target lesion was located in the right coronary artery.A 2.50mm x 20mm nc emerge balloon catheter was advanced for post dilatation.However, during the first inflation at nominal pressure for approximately 5 seconds, the balloon ruptured.When the device was attempted to remove, the catheter got separated and the distal part of the balloon remained in the patient's body.About three quarters of the device was removed.The patient was transferred emergently for surgical intervention.The bypassed procedure was successfully performed and the retained portion of the device was removed from the artery.No further patient complications were reported.
 
Event Description
It was reported that balloon rupture and shaft break occurred.The target lesion was located in the right coronary artery.A 2.50mm x 20mm nc emerge balloon catheter was advanced for post dilatation.However, during the first inflation at nominal pressure for approximately 5 seconds, the balloon ruptured.When the device was attempted to remove, the catheter got separated and the distal part of the balloon remained in the patient's body.About three quarters of the device was removed.The patient was transferred emergently for surgical intervention.The bypassed procedure was successfully performed and the retained portion of the device was removed from the artery.No further patient complications were reported.It was further reported that the patient was admitted due to chest pain and acute myocardial infarction.The patient underwent aortocoronary bypass grafting x 5 disuse 4- vessel coronary artery disease.The patient was discharged to an inpatient rehabilitation facility and was doing well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8128295
MDR Text Key129161732
Report Number2134265-2018-63333
Device Sequence Number1
Product Code LOX
UDI-Device Identifier08714729846635
UDI-Public08714729846635
Combination Product (y/n)N
PMA/PMN Number
K141236
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2020
Device Model Number7214
Device Catalogue Number7214
Device Lot Number0022732903
Was Device Available for Evaluation? No
Date Manufacturer Received01/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-